Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Am J Med Genet A. 2010 Mar;152A(3):601-6. doi: 10.1002/ajmg.a.33271.
We present monozygotic twins discordant for the autosomal dominant disorder neurofibromatosis type 1 (NF1). The affected twin was diagnosed with NF1 at age 12, based upon accepted clinical criteria for the disorder. Both twins were re-examined at ages 35 and 57, at which times the unaffected twin continued to show no clinical manifestations of NF1. Short tandem repeat marker (STR) genotyping at 10 loci on chromosome 17 and 10 additional loci dispersed across the genome revealed identical genotypes for the twins, confirming their monozygosity. The affected twin has three children, two of whom also have NF1, while the unaffected twin has two children, both unaffected. Using lymphoblastoid, fibroblast, and buccal cell samples collected from both twins and from other family members in three generations, we discovered a pathogenic nonsense mutation in exon 40 of the NF1 gene. This mutation was found in all cell samples from the affected twin and her affected daughter, and in lymphoblastoid and buccal cells but not fibroblasts from the unaffected twin. We also found a novel non-synonymous change in exon 16 of the NF1 gene that was transmitted from the unaffected mother to both twins and co-segregated with the pathogenic mutation in the ensuing generation. All cells from the twins were heterozygous for this apparent exon 16 polymorphism and for single nucleotide polymorphisms (SNPs) within 2.5 kb flanking the site of the exon 40 nonsense mutation. This suggests that the NF1 gene of the unaffected twin differed in the respective lymphoblastoid cells and fibroblasts only at the mutation site itself, making post-zygotic mutation leading to mosaicism the most likely mechanism of phenotypic discordance. Although the unaffected twin is a mosaic, the distribution of the mutant allele among different cells and tissues appears to be insufficient to cause overt clinical manifestations of NF1.
我们介绍了一对同卵双胞胎,她们患有常染色体显性遗传疾病神经纤维瘤病 1 型(NF1)。受影响的双胞胎在 12 岁时被诊断患有 NF1,依据该疾病的公认临床标准。在 35 岁和 57 岁时,对这对双胞胎进行了重新检查,此时未受影响的双胞胎仍然没有表现出 NF1 的临床症状。在 17 号染色体上的 10 个短串联重复标记(STR)基因座和散布在基因组中的另外 10 个基因座上进行的 STR 基因分型显示,双胞胎具有相同的基因型,证实了她们的同卵性。受影响的双胞胎有三个孩子,其中两个也患有 NF1,而未受影响的双胞胎有两个孩子,均未受影响。使用取自双胞胎及其三代家族成员的淋巴细胞、成纤维细胞和口腔细胞样本,我们发现了 NF1 基因外显子 40 中的一个致病性无义突变。该突变存在于受影响的双胞胎及其患病女儿的所有细胞样本中,而在未受影响的双胞胎的淋巴细胞和口腔细胞中存在,但在成纤维细胞中不存在。我们还发现了 NF1 基因外显子 16 中的一个新的非同义变化,该变化由未受影响的母亲传给了双胞胎,并在外显子 40 无义突变的后代中与致病突变共分离。来自双胞胎的所有细胞均对此明显的外显子 16 多态性以及外显子 40 无义突变位点侧翼的 2.5 kb 内的单核苷酸多态性(SNP)呈杂合状态。这表明,未受影响的双胞胎的 NF1 基因仅在外显子 40 突变位点本身的淋巴细胞和成纤维细胞中存在差异,导致合子后突变导致嵌合体的可能性最大。尽管未受影响的双胞胎是嵌合体,但突变等位基因在不同细胞和组织中的分布似乎不足以导致 NF1 的明显临床表现。